New trends for metal complexes with anticancer activity, Curr Opin Chem Biol, vol.12, pp.197-206, 2008. ,
Antitumour metal compounds: more than theme and variations, pp.183-94, 2008. ,
Metal-based antitumour drugs in the post genomic era, pp.1929-1962, 2006. ,
The resurgence of platinum-based cancer chemotherapy, Nat Rev Cancer, vol.7, pp.573-84, 2007. ,
Neurologic complications of chemotherapy agents, Curr Opin Neurol, vol.20, pp.719-744, 2007. ,
Toxicities of the platinum antineoplastic agents, Expert Opin Drug Saf, vol.2, pp.597-607, 2003. ,
Ruthenium in medicine: current clinical uses and future prospects, Platinum Metals Rev, vol.45, p.62, 2001. ,
The in vivo inhibition of tumor growth by ruthenium red: its relationship with the metabolism of calcium in the tumor, Z Krebsforsch Klin Onkol Cancer Res Clin Oncol, vol.83, pp.213-220, 1975. ,
Antitumor action of two rhodium and ruthenium complexes in comparison with cis-diamminedichloroplatinum(II), Cancer Res, vol.37, pp.2662-2668, 1977. ,
Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis -dichlorodiammino platinum(II) in mice bearing Lewis lung carcinoma, Chem Biol Interact, vol.45, pp.1-6, 1983. ,
Synthesis and antitumor activity of triazolium-bis(triazole)-tetrachlororuthenate (III) and bistriazolium-triazolepentachlororuthenate (III), Arzneimittelforschung, vol.37, pp.770-771, 1987. ,
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in the Lewis lung carcinoma system, Pharmacol Res, vol.21, pp.617-645, 1989. ,
New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells, Cancer Res, vol.51, pp.2943-2951, 1991. ,
Correlation between cytotoxicity and DNA binding of polypyridyl ruthenium complexes, Biochemistry, vol.34, pp.12369-78, 1995. ,
Inhibition of cancer cell growth by ruthenium(II) arene complexes, J Med Chem, vol.44, pp.3616-3637, 2001. ,
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes, J Med Chem, vol.48, pp.4161-71, 2005. ,
Preclinical activity of trans-indazolium[tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells, Eur J Cancer, vol.33, pp.2404-2414, 1997. ,
Ruthenium-based NAMI-A type complexes with in vivo selective metastasis reduction and in vitro invasion inhibition unrelated to cell cytotoxicity, Int J Oncol, vol.21, pp.1331-1339, 2002. ,
Binding of cis -and trans-dichlorodiammineplatinum(II) to DNA: evidence for unwinding and shortening of the double helix, Science, vol.203, pp.1014-1020, 1979. ,
Tris(tetramethylphenanthroline) ruthenium(II): a chiral probe that cleaves A-DNA conformations, Proc Natl Acad Sci U S A, vol.85, pp.1339-1382, 1988. ,
DNA modifications by antitumor platinum and ruthenium compounds: their recognition and repair, Prog Nucleic Acid Res Mol Biol, vol.71, pp.1-68, 2002. ,
Metallo-intercalators and metallo-insertors, Chem Commun (Camb), pp.4565-79, 2007. ,
Ruthenium (II)-derived organometallic compounds induce cytostatic and cytotoxic effects on mammalian cancer cell lines through p53-dependent and p53-independent mechanisms, J Pharmacol Exp Ther, vol.315, pp.1403-1414, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-02360373
Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175, Cancer Chemother Pharmacol, vol.55, pp.577-83, 2005. ,
The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways, J Biol Inorg Chem, vol.13, pp.1149-55, 2008. ,
Redoxactive antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potential, J Med Chem, vol.48, pp.2831-2838, 2005. ,
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells, Cancer Res, vol.67, pp.209-226, 2007. ,
Organometallic ruthenium inhibitors of glutathione-S -transferase P1-1 as anticancer drugs, ChemMedChem, 2007. ,
Catalytic organometallic anticancer complexes, Cancer Research Cancer Res, vol.105, issue.13, pp.11628-11661, 2008. ,
Synthesis of cycloruthenated compounds as potential anticancer agents, Eur J Inorg Chem, pp.3055-66, 2007. ,
Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis, Cell Death Differ, 2007. ,
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry, J Immunol Methods, vol.139, pp.271-280, 1991. ,
Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival, Cell Death Differ, vol.14, pp.1802-1814, 2007. ,
Characterization of human NIPK (TRB3, SKIP3) gene activation in stressful conditions, Biochem Biophys Res Commun, vol.330, pp.210-218, 2005. ,
Fibrates upregulate TRB3 in lymphocytes independent of PPARa by augmenting CCAAT/enhancer-binding protein h (C/ EBPh) expression, Mol Immunol, vol.44, pp.1218-1247, 2007. ,
CHOP transcription factor phosphorylation by casein kinase 2 inhibits transcriptional activation, J Biol Chem, vol.278, pp.40514-40534, 2003. ,
Amino acids control mammalian gene transcription: activating transcription factor 2 is essential for the amino acid responsiveness of the CHOP promoter, Mol Cell Biol, vol.20, pp.7192-204, 2000. ,
The Bax Inhibitor-1 (BI-1) family in apoptosis and tumorigenesis, Curr Mol Med, vol.8, pp.148-56, 2008. ,
The p53 family and programmed cell death, Oncogene, vol.27, pp.6507-6528, 2008. ,
Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair, Mol Cell, vol.18, pp.617-639, 2005. ,
Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling, J Biol Chem, vol.278, pp.9100-9106, 2003. ,
ER stress regulation of ATF6 localization by dissociation of BiP/ GRP78 binding and unmasking of Golgi localization signals, Dev Cell, vol.3, pp.99-111, 2002. ,
Signal integration in the endoplasmic reticulum unfolded protein response, Nat Rev Mol Cell Biol, vol.8, pp.519-548, 2007. ,
CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum, Genes Dev, vol.18, pp.3066-77, 2004. ,
CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum, Genes Dev, vol.12, pp.982-95, 1998. ,
Roles of CHOP/GADD153 in endoplasmic reticulum stress, Cell Death Differ, vol.11, pp.381-390, 2004. ,
CHAC1/MGC4504 is a novel proapoptotic component of the unfolded protein response, downstream of the ATF4-3-CHOP cascade, J Immunol, vol.182, pp.466-76, 2009. ,
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage, Nature, vol.399, pp.806-815, 1999. ,
PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2, Nat Cell Biol, vol.4, pp.865-70, 2002. ,
DNA damage-induced apoptosis, Cancer Res Xiangjun Meng, vol.23, pp.5458-5466, 2004. ,